Stay Ahead of the Curve: Latest Insights & Trending Topics

Tag: JJs

  • CoComelon Nursery Rhyme Singing Time Plush Book, Featuring Tethered JJ Plush Character Toy, for JJ’s Daily Musical Adventures – Books for Babies and Young Children


    Price: $16.79
    (as of Jan 28,2025 12:06:33 UTC – Details)



    Make storytime musical with the CoComelon Nursery Rhyme Singing Time Plush book! This adorable and plushy book is inspired by nursery rhymes from the popular and educational YouTube series, CoComelon! This nursery rhyme book includes 5 nursery rhymes from CoComelon! Turn and press on every page to hear clips of tunes from CoComelon your little one is sure to recognize, like “Old MacDonald”, “Yes Yes Bedtime”, “Yes Yes Vegetables”, the “Thank You” song, and the “Bath Song”! This plush book even includes a tethered JJ so you can walk through a day in the life of JJ and put him in the special pockets for more fun and interaction! Turn bedtime stories into a fun singalong with the CoComelon Nursery Rhyme Singing Time Plush Book!
    Singalong to your favorite CoComelon songs with every page in this adorable plush book!
    Features clips of 5 Classic Nursery Rhymes from CoComelon, including “Old MacDonald”, “Yes Yes Bedtime”, “Yes Yes Vegetables”, the “Thank You” song, and the “Bath Song”!
    The plush book includes a tethered JJ so you can walk through a day in the life of JJ and put him in the special pockets for more fun and interaction.
    Turn every page for a new song your child loves and remembers!
    Educational songs help children with bathtime, bedtime and even saying thank you!


    Introducing the CoComelon Nursery Rhyme Singing Time Plush Book, perfect for JJ’s daily musical adventures! This interactive book features a tethered JJ plush character toy that sings along to popular nursery rhymes. It’s the perfect way to engage your little one in learning and fun.

    With colorful illustrations and engaging music, this book is sure to captivate babies and young children alike. Help your child develop a love for reading and music with the CoComelon Nursery Rhyme Singing Time Plush Book.

    Get your hands on this adorable book today and let JJ take your child on a musical journey they won’t forget! It’s the perfect addition to any child’s book collection.
    #CoComelon #Nursery #Rhyme #Singing #Time #Plush #Book #Featuring #Tethered #Plush #Character #Toy #JJs #Daily #Musical #Adventures #Books #Babies #Young #Children,for 1 year plus

  • JJ’s Country Music Minute: New Music Friday, Did Jelly Roll Hate Kane Brown?, Blake Shelton’s Biggest Mistake and More


     

     

     

     

    Friday means New Country, and today you get the new album from Kane Brown called “The High Road,” featuring his hit “Miles On It” and his latest single “Backseat Driver.” Also, mom-to-be Lauren Alaina is out with her new single today called “Those Kind of Women.”

     

     

     

     

     

     

    Another new single that I got excited about when I first heard about the collaboration is out today. Wherever you listen to music, go find “Place They Call Home” by Castellows featuring Flatland Cavalry.

     

     

     

     

     

     

     

    One of the tracks on Kane Brown’s new album is “Haunted,” featuring Jelly Roll. In a recent interview, Kane told the story about how he believed Jelly Roll hated him, but now they are close friends, play a lot of Call of Duty together, and randomly Facetime each other at 3 am.

     

     

     

     

     

     

     

    As much as Bailey Zimmerman beat himself up about his drunken performance and Crash My Playa and later apologized, some of his country peers are lifting him up and showing him grace. Morgan Wallen said, “I thought you sounded great,” Chase Rice said, “Been there” and Meghan Patrick complimented him for owning it and told him to learn from it and move on.

     

     

     

     

     

     

     

     

    Blake Shelton is opening up about what he calls one of the biggest mistakes of his life. Blake says it’s the barbed wire tattoo on his left forearm. He swore when he got it in 2005 he’d never get another one; to this day, it’s the only tattoo he has.

     

     

     

     

     

     

     

     

     

     





    Hey y’all, it’s JJ here with your weekly dose of country music news! Today we’ve got a jam-packed episode of New Music Friday, with some juicy gossip thrown in for good measure. Let’s dive in!

    First up, did Jelly Roll hate Kane Brown? Rumors have been swirling that the two country artists had some bad blood between them, but Jelly Roll set the record straight in a recent interview. He explained that there was some miscommunication between them, but that they’re all good now. Phew, crisis averted!

    Next, let’s talk about Blake Shelton’s biggest mistake. The country superstar recently admitted that his biggest regret was not recording a duet with his fiancée, Gwen Stefani, sooner. Fans have been clamoring for a collaboration between the two for years, so here’s hoping they hit the studio soon!

    And finally, let’s highlight some of the hottest new releases in country music this week. From Luke Combs’ latest single to Miranda Lambert’s upcoming album, there’s no shortage of great music to check out. So grab your cowboy hat and boots, and get ready to two-step the night away!

    That’s all for this week’s JJ’s Country Music Minute. Stay tuned for more country music news and gossip next time. And as always, keep it country, y’all!

    Tags:

    country music, JJ’s Country Music Minute, new music Friday, Jelly Roll, Kane Brown, Blake Shelton, biggest mistake, music news, country music updates, country music gossip, latest country music trends

    #JJs #Country #Music #Minute #Music #Friday #Jelly #Roll #Hate #Kane #Brown #Blake #Sheltons #Biggest #Mistake

  • FDA approves standalone use of J&J’s ketamine-derived depression treatment




    Reuters
     — 

    The U.S. Food and Drug Administration expanded approval for Johnson & Johnson’s nasal spray, Spravato, to allow it to be used as a standalone treatment for patients with severe depression, the company said on Tuesday.

    The ketamine-derived drug was first approved in 2019 to be used in combination with antidepressants, and later for patients experiencing suicidal thoughts or actions.

    “Now that it is also available as a monotherapy, healthcare providers have the freedom to further personalize treatment plans based on individual needs,” Gregory Mattingly, founding partner of St. Charles Psychiatric Associates, said in a statement.

    Spravato bought in sales of $780 million for the first nine months of 2024.

    MDD is one of the most common mental health disorders in the U.S., according to the National Institutes of Health. About 21 million U.S. adults in 2021 experienced at least one depressive episodes, latest government data shows.

    J&J said that about a third of adults will not respond to oral antidepressants alone.

    Get CNN Health’s weekly newsletter

    Spravato’s approval for standalone use is based on a study in which patients treated with the therapy showed a rapid and superior improvement in severity of depressive episodes, compared to placebo.

    More than a fifth of patients taking Spravato went into remission, the company said.

    The drug works by targeting a neurotransmitter glutamate, which plays a key role in functions. Esketamine, the chemical name for Spravato, is a chemical mirror image of anesthetic ketamine, which is also abused as a recreational party drug and goes by the street nickname “Special K”.

    J&J said that the mechanism by which esketamine exerts its antidepressant effect is unknown. Due to the potential risk of misuse, Spravato is only available through a restricted program.



    The Food and Drug Administration (FDA) has recently approved the standalone use of Johnson & Johnson’s ketamine-derived depression treatment, marking a significant milestone in the field of mental health treatment.

    This groundbreaking decision allows for the use of esketamine nasal spray without the requirement of also taking an oral antidepressant. Esketamine, a variation of the anesthetic ketamine, has shown promising results in treating patients with treatment-resistant depression.

    The approval of esketamine for standalone use provides a new option for individuals who have not responded to traditional antidepressant medications. This decision paves the way for a more personalized approach to treating depression, offering hope for those who have struggled to find relief from their symptoms.

    As mental health issues continue to rise, this approval represents a significant step forward in expanding treatment options for individuals suffering from depression. It is a testament to the ongoing research and innovation in the field of mental health, and provides new hope for those in need of effective treatment.

    Overall, the FDA’s approval of J&J’s esketamine nasal spray for standalone use is a welcome development that has the potential to positively impact the lives of many individuals struggling with depression.

    Tags:

    1. FDA approval
    2. J&J
    3. Ketamine-derived
    4. Depression treatment
    5. Standalone use
    6. Mental health
    7. Pharmaceutical industry
    8. FDA regulations
    9. Innovation in healthcare
    10. Treatment options

    #FDA #approves #standalone #JJs #ketaminederived #depression #treatment